{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Oracle,", "Eli", "Lilly,", "Mondelez,", "Walgreens", "and", "Southwest"], "created_at": "2019-06-11 15:19:03"}
{"text": ["Merck", "(MRK)", "to", "Buy", "Private", "Biotech", "Tilos", "for", "Up", "to", "$773M"], "created_at": "2019-06-11 15:14:45"}
{"text": ["Merck", "(MRK)", "to", "Buy", "Private", "Biotech", "Tilos", "for", "Up", "to", "$773M"], "created_at": "2019-06-11 15:14:45"}
{"text": ["Lilly", "Announces", "Tradjenta", "Cardiovascular", "Outcome", "Study", "Data"], "created_at": "2019-06-11 15:14:31"}
{"text": ["Lilly", "Announces", "Tradjenta", "Cardiovascular", "Outcome", "Study", "Data"], "created_at": "2019-06-11 15:14:31"}
{"text": ["Lilly", "Announces", "Tradjenta", "Cardiovascular", "Outcome", "Study", "Data"], "created_at": "2019-06-11 13:03:01"}
{"text": ["Merck", "(MRK)", "to", "Buy", "Private", "Biotech", "Tilos", "for", "Up", "to", "$773M"], "created_at": "2019-06-11 12:53:12"}
{"text": ["See", "what", "the", "IHS", "Markit", "Score", "report", "has", "to", "say", "about", "Eli", "Lilly", "and", "Co."], "created_at": "2019-06-11 12:00:40"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Lilly", "Reports", "Positive", "Long-Term", "Efficacy", "Data", "For", "Psoriasis", "Drug,", "Provention", "Bio", "Offering"], "created_at": "2019-06-11 11:34:08"}
{"text": ["Lilly", "to", "Present", "5-Year", "Sustained", "Efficacy", "and", "Safety", "Results", "for", "Taltz\u00ae", "(ixekizumab)", "in", "Patients", "with", "Plaque", "Psoriasis", "at", "the", "World", "Congress", "of", "Dermatology"], "created_at": "2019-06-11 07:00:00"}
{"text": ["Detailed", "findings", "from", "CAROLINA\u00ae", "outcome", "trial", "support", "long-term", "cardiovascular", "safety", "profile", "of", "Tradjenta\u00ae"], "created_at": "2019-06-11 01:30:00"}
